Vera A. Gorbounova
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: July 26, 2018
Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms.
Journal: Neuroendocrinology
Published: July 02, 2018
Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma.
Journal: Cancer chemotherapy and pharmacology
Published: February 28, 2017
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents.
Journal: Neuroendocrinology
Published: December 12, 2016
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology: Diagnosis and Prognostic Stratification.
Journal: Neuroendocrinology
Published: November 08, 2016
Characteristics of Patients with Pleural Mesothelioma in the Russian Federation.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
DISRUPT: a randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane-platinum regimen as first-line therapy for metastatic non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 19, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026